These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 29492713)

  • 1. Fractional CO
    Becorpi A; Campisciano G; Zanotta N; Tredici Z; Guaschino S; Petraglia F; Pieralli A; Sisti G; De Seta F; Comar M
    Lasers Med Sci; 2018 Jul; 33(5):1047-1054. PubMed ID: 29492713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors.
    Quick AM; Zvinovski F; Hudson C; Hundley A; Evans C; Suresh A; Stephens JA; Arthur E; Ramaswamy B; Reinbolt RE; Noonan AM; VanDeusen JB; Wesolowski R; Stover DG; Williams NO; Sardesai SD; Smith KL; Faubion SS; Loprinzi CL; Lustberg MB
    Support Care Cancer; 2020 Aug; 28(8):3669-3677. PubMed ID: 31811486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Short-term efficacy of vaginal CO
    Kozma B; Póka R; Sipos A; Ács N; Takács P
    Orv Hetil; 2019 Oct; 160(41):1617-1622. PubMed ID: 31587579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis.
    Filippini M; Porcari I; Ruffolo AF; Casiraghi A; Farinelli M; Uccella S; Franchi M; Candiani M; Salvatore S
    J Sex Med; 2022 Mar; 19(3):452-470. PubMed ID: 35101378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors.
    Pieralli A; Fallani MG; Becorpi A; Bianchi C; Corioni S; Longinotti M; Tredici Z; Guaschino S
    Arch Gynecol Obstet; 2016 Oct; 294(4):841-6. PubMed ID: 27170261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Double-Blind Randomized Sham-Controlled Trial to Evaluate the Efficacy of Fractional Carbon Dioxide Laser Therapy on Genitourinary Syndrome of Menopause.
    Cruff J; Khandwala S
    J Sex Med; 2021 Apr; 18(4):761-769. PubMed ID: 33757774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and long-term efficacy of fractional CO
    Behnia-Willison F; Sarraf S; Miller J; Mohamadi B; Care AS; Lam A; Willison N; Behnia L; Salvatore S
    Eur J Obstet Gynecol Reprod Biol; 2017 Jun; 213():39-44. PubMed ID: 28419911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genitourinary syndrome of menopause and the use of laser therapy.
    Hutchinson-Colas J; Segal S
    Maturitas; 2015 Dec; 82(4):342-5. PubMed ID: 26323234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractional CO
    Lang P; Dell JR; Rosen L; Weiss P; Karram M
    Lasers Surg Med; 2017 Dec; 49(10):882-885. PubMed ID: 28881431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost-effectiveness analysis of vaginal carbon dioxide laser therapy compared with standard medical therapies for genitourinary syndrome of menopause-associated dyspareunia.
    Wallace SL; St Martin B; Lee K; Sokol ER
    Am J Obstet Gynecol; 2020 Dec; 223(6):890.e1-890.e12. PubMed ID: 32562659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Fractional CO
    Li J; Li H; Zhou Y; Xie M; Miao Y; Wang L; Zhao Y; Ying T; Hu Y; Chen Y; Chen Y; Sun X; Wang J
    Lasers Surg Med; 2021 Jul; 53(5):647-653. PubMed ID: 33211334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design for fractional microablative CO
    Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
    Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microablative fractional CO
    Pitsouni E; Grigoriadis T; Falagas M; Tsiveleka A; Salvatore S; Athanasiou S
    Lasers Med Sci; 2017 Nov; 32(8):1865-1872. PubMed ID: 28770400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal laser therapy for GSM/VVA: where we stand now - a review by the EUGA Working Group on Laser.
    Salvatore S; Ruffolo AF; Phillips C; Athanasiou S; Cardozo L; Serati M;
    Climacteric; 2023 Aug; 26(4):336-352. PubMed ID: 37395104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes.
    Sokol ER; Karram MM
    Menopause; 2017 Jul; 24(7):810-814. PubMed ID: 28169913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a vaginal CO
    Mejia-Gomez J; Bouteaud J; Philippopoulos E; Wolfman W; Brezden-Masley C
    Climacteric; 2022 Jun; 25(3):228-234. PubMed ID: 34694948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microablative fractional CO
    Pitsouni E; Grigoriadis T; Tsiveleka A; Zacharakis D; Salvatore S; Athanasiou S
    Maturitas; 2016 Dec; 94():131-136. PubMed ID: 27823733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual Function in Women Suffering From Genitourinary Syndrome of Menopause Treated With Fractionated CO
    Salvatore S; Pitsouni E; Del Deo F; Parma M; Athanasiou S; Candiani M
    Sex Med Rev; 2017 Oct; 5(4):486-494. PubMed ID: 28843942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser therapy for the restoration of vaginal function.
    Gambacciani M; Palacios S
    Maturitas; 2017 May; 99():10-15. PubMed ID: 28364861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of promestriene with vaginal fractional CO2 laser and radiofrequency treatments of genitourinary syndrome of menopause.
    Seganfredo IB; Bianchi C; Tacla M; Chedraui P; Haddad JM; Simoes R; Baracat EC; Soares JM
    Maturitas; 2024 Aug; 186():108008. PubMed ID: 38714422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.